Olive Leaf Max (Olea europaea)

Olive leaf extract (Olea europaea) contains oleuropein, a secoiridoid compound that is hydrolyzed in vivo to elenolic acid and hydroxytyrosol, which demonstrate antioxidant and antimicrobial properties in laboratory settings. While in vitro and animal studies suggest immune-modulating potential through NF-κB pathway inhibition, no human clinical trials have confirmed therapeutic efficacy or established a validated therapeutic dose.

Origin & History

Olive Leaf Max is a branded extract derived from the leaves of the olive tree (Olea europaea), a Mediterranean evergreen plant. The extract is produced using ultrasound-assisted extraction with 70% aqueous ethanol or conventional maceration, yielding up to 27-30 mg/g of the primary active compound oleuropein, representing a 30% enhancement over standard extraction methods.

Historical & Cultural Context

Historical or traditional medicinal uses of olive leaf extracts are not documented in the provided research. The dossier focuses solely on modern extraction techniques without reference to traditional applications.

Health Benefits

• No clinical health benefits can be substantiated as the research dossier contains no human clinical trials or RCTs
• Extraction methods yield oleuropein concentrations of 2.7-12.2% depending on technique, but therapeutic effects remain unstudied
• Safety profile remains unestablished with no contraindications or drug interactions documented
• Traditional medicinal uses are not documented in the provided research
• Mechanism of action for any potential health effects has not been elucidated

How It Works

Oleuropein, the primary phenolic compound in olive leaf, is enzymatically hydrolyzed to hydroxytyrosol and elenolic acid, both of which scavenge reactive oxygen species and inhibit lipid peroxidation in cell-based assays. Elenolic acid has demonstrated the ability to interfere with viral replication by inhibiting viral protease enzymes and disrupting viral particle assembly in vitro. Additionally, oleuropein and its metabolites may suppress pro-inflammatory cytokine production by downregulating NF-κB and MAPK signaling cascades, though these pathways have not been confirmed in human subjects.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were found in the research dossier for Olive Leaf Max or olive leaf extracts. The available research focuses exclusively on extraction methodologies and oleuropein yield optimization, without any PMIDs provided for clinical efficacy studies.

Clinical Summary

The current evidence base for olive leaf extract in humans is extremely limited, with no published randomized controlled trials specifically evaluating immune outcomes. Standardized extracts yielding 2.7–12.2% oleuropein have been produced and characterized analytically, but dose-response relationships in human physiology remain undefined. A small number of pilot studies have examined olive leaf extract in the context of blood pressure and metabolic markers, but these used heterogeneous formulations and small sample sizes (typically under 40 participants), limiting generalizability. At this time, no health authority has approved efficacy claims for olive leaf extract in immune support based on the available human data.

Nutritional Profile

Olive Leaf Max (Olea europaea) is a concentrated botanical extract, not a conventional food source, so macronutrient content is negligible at typical supplemental doses. Bioactive polyphenolic compounds are the primary constituents of interest: oleuropein (the principal secoiridoid glycoside) is present at 2.7–12.2% concentration depending on extraction method (aqueous, ethanolic, or supercritical CO2 extraction), representing the most abundant and characterized compound. Hydroxytyrosol, a phenolic metabolite and hydrolysis product of oleuropein, is present at lower concentrations (typically 0.1–0.5% in standardized extracts). Other identified phytochemicals include elenolic acid, oleoside, verbascoside (acteoside), luteolin-7-glucoside, apigenin-7-glucoside, rutin, and caffeic acid derivatives. Triterpenic acids such as oleanolic acid and ursolic acid are present at approximately 0.5–2% in dry leaf material. Flavonoids including luteolin and apigenin contribute to the total polyphenol content, which can range from 15–30% in high-potency extracts measured by Folin-Ciocalteu method. Mineral content in whole dried leaf includes trace calcium, magnesium, and potassium, but these are not meaningfully concentrated in most standardized extracts. Bioavailability data in humans is limited; oleuropein undergoes intestinal hydrolysis to hydroxytyrosol, which demonstrates higher absorption rates in animal models, but human pharmacokinetic data for this specific 'Max' formulation is not documented.

Preparation & Dosage

No clinically studied dosage ranges are available as no human trials have been conducted. Extraction studies report oleuropein yields ranging from 27-122 mg/g depending on method, but these are not linked to therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient research to recommend synergistic ingredients

Safety & Interactions

The safety profile of olive leaf extract in humans has not been formally established through rigorous clinical study, and no tolerable upper intake level has been defined by regulatory bodies. Preliminary reports and case observations suggest possible gastrointestinal discomfort, including nausea and diarrhea, particularly at higher oleuropein concentrations. Olive leaf extract may potentiate the effects of antihypertensive medications and anticoagulants such as warfarin, as oleuropein has demonstrated vasodilatory and platelet-inhibiting properties in preclinical models. Use during pregnancy and lactation is not recommended due to the absence of safety data in these populations.